Abstract
Thyroid dysfunction in pregnancy is strongly associated with adverse maternal and foetal outcomes. The effects of treatment are less clear. There is ongoing discussion on whom to treat, when to treat and whether treatment is beneficial. Although universal screening for thyroid disease during pregnancy increases diagnosis and treatment of thyroid dysfunction, there is currently insufficient evidence demonstrating a positive effect of screening on maternal and foetal outcomes. We therefore, at present, recommend against universal screening for thyroid disease before and during pregnancy.
Original language | English |
---|---|
Article number | 101429 |
Journal | Best practice & research. Clinical endocrinology & metabolism |
Volume | 34 |
Issue number | 4 |
Early online date | 2020 |
DOIs | |
Publication status | Published - Jul 2020 |
Keywords
- miscarriage
- pregnancy
- premature delivery
- screening
- thyroid autoimmunity
- thyroid hormone